Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability
Sign Up to like & getrecommendations! Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox11102077
Abstract: Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting… read more here.
Keywords: promotes head; head neck; hemoxygenase promotes; viability ... See more keywords